Eam Investors, LLC Karuna Therapeutics, Inc. Transaction History

Eam Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $770,333 - $952,490	-4,022 Reduced 45.99%	4,723 $928,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $1.08 Million - $2.43 Million	8,745 New	8,745 $1.97 Million
Q3 2020 Nov 13, 2020	SELL	$71.31 - $109.74 $1.67 Million - $2.57 Million	-23,463 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$62.14 - $117.21 $1.06 Million - $2 Million	-17,053 Reduced 42.09%	23,463 $2.62 Million
Q1 2020 May 13, 2020	BUY	$60.41 - $115.92 $124,988 - $239,838	2,069 Added 5.38%	40,516 $2.92 Million
Q4 2019 Feb 11, 2020	BUY	$11.44 - $123.99 $439,833 - $4.77 Million	38,447 New	38,447 $2.9 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.